Product Information
MEDROXYPROGESTERONE 2.5 MG TAB is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.1156 per EA under NDC 59762005501. Its NADAC has been published 419 times since Sep 26, 2018.
FDA first approved this application before 1982. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
59762005501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
MEDROXYPROGESTERONE ACETATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA011839FDA Approved
Before 1982
TE Code
AB
On Market Since
8/19/2018
Pharmacological Classes
Price Statistics
The NADAC for MEDROXYPROGESTERONE 2.5 MG TAB has been published 419 times since Sep 26, 2018, and over the history we have for it it has risen 6.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1156 per EA |
|---|---|
| All-time high | $0.1196 (Jan 14, 2026) |
| All-time low | $0.0883 (Apr 17, 2024) |
| 52-week high | $0.1196 |
| 52-week low | $0.1141 |
| Median price | $0.1072 |
| Average price | $0.1073 |
| Largest weekly change | +21.1% (Aug 21, 2024) |
| Weeks tracked | 419 |
| Tracking since | Sep 26, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Mylan Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
medroxyprogesterone acetate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Progestin class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MEDROXYPROGESTERONE 2.5 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for MEDROXYPROGESTERONE 2.5 MG TAB, manufactured by Mylan Pharmaceuticals Inc., is $0.1156 per EA (NDC 59762005501), effective Sep 30, 2026.
How has the price of MEDROXYPROGESTERONE 2.5 MG TAB changed over time?
Over the history we have for it, the NADAC for MEDROXYPROGESTERONE 2.5 MG TAB has risen 6.0%. It has been tracked across 419 weekly CMS publications since Sep 26, 2018.
What are the highest and lowest recorded NADAC prices for MEDROXYPROGESTERONE 2.5 MG TAB?
Since Sep 26, 2018, the NADAC for MEDROXYPROGESTERONE 2.5 MG TAB has ranged from a low of $0.0883 (Apr 17, 2024) to a high of $0.1196 (Jan 14, 2026), with a median of $0.1072 per EA.
Are there cheaper alternatives to MEDROXYPROGESTERONE 2.5 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as MEDROXYPROGESTERONE 2.5 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures MEDROXYPROGESTERONE 2.5 MG TAB?
MEDROXYPROGESTERONE 2.5 MG TAB (NDC 59762005501) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.